These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 25420526)
1. Two-pore domain potassium channels: potential therapeutic targets for the treatment of pain. Mathie A; Veale EL Pflugers Arch; 2015 May; 467(5):931-43. PubMed ID: 25420526 [TBL] [Abstract][Full Text] [Related]
2. TRESK and TREK-2 two-pore-domain potassium channel subunits form functional heterodimers in primary somatosensory neurons. Lengyel M; Czirják G; Jacobson DA; Enyedi P J Biol Chem; 2020 Aug; 295(35):12408-12425. PubMed ID: 32641496 [TBL] [Abstract][Full Text] [Related]
3. Leak K⁺ channel mRNAs in dorsal root ganglia: relation to inflammation and spontaneous pain behaviour. Marsh B; Acosta C; Djouhri L; Lawson SN Mol Cell Neurosci; 2012 Mar; 49(3):375-86. PubMed ID: 22273507 [TBL] [Abstract][Full Text] [Related]
4. [Two-pore-domain potassium channels and molecular mechanisms underlying migraine]. Royal P; Ávalos Prado P; Wdziekonski B; Sandoz G Biol Aujourdhui; 2019; 213(1-2):51-57. PubMed ID: 31274103 [TBL] [Abstract][Full Text] [Related]
5. Role of leak potassium channels in pain signaling. Li XY; Toyoda H Brain Res Bull; 2015 Oct; 119(Pt A):73-9. PubMed ID: 26321392 [TBL] [Abstract][Full Text] [Related]
9. Role of the TREK2 potassium channel in cold and warm thermosensation and in pain perception. Pereira V; Busserolles J; Christin M; Devilliers M; Poupon L; Legha W; Alloui A; Aissouni Y; Bourinet E; Lesage F; Eschalier A; Lazdunski M; Noël J Pain; 2014 Dec; 155(12):2534-2544. PubMed ID: 25239074 [TBL] [Abstract][Full Text] [Related]
10. GI-530159, a novel, selective, mechanosensitive two-pore-domain potassium (K Loucif AJC; Saintot PP; Liu J; Antonio BM; Zellmer SG; Yoger K; Veale EL; Wilbrey A; Omoto K; Cao L; Gutteridge A; Castle NA; Stevens EB; Mathie A Br J Pharmacol; 2018 Jun; 175(12):2272-2283. PubMed ID: 29150838 [TBL] [Abstract][Full Text] [Related]
11. Migraine-Associated TRESK Mutations Increase Neuronal Excitability through Alternative Translation Initiation and Inhibition of TREK. Royal P; Andres-Bilbe A; Ávalos Prado P; Verkest C; Wdziekonski B; Schaub S; Baron A; Lesage F; Gasull X; Levitz J; Sandoz G Neuron; 2019 Jan; 101(2):232-245.e6. PubMed ID: 30573346 [TBL] [Abstract][Full Text] [Related]
12. Heterodimerization within the TREK channel subfamily produces a diverse family of highly regulated potassium channels. Levitz J; Royal P; Comoglio Y; Wdziekonski B; Schaub S; Clemens DM; Isacoff EY; Sandoz G Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4194-9. PubMed ID: 27035963 [TBL] [Abstract][Full Text] [Related]
13. Selective and state-dependent activation of TRESK (K Lengyel M; Dobolyi A; Czirják G; Enyedi P Br J Pharmacol; 2017 Jul; 174(13):2102-2113. PubMed ID: 28419410 [TBL] [Abstract][Full Text] [Related]
14. DCPIB, an Inhibitor of Volume-Regulated Anion Channels, Distinctly Modulates K2P Channels. Lv J; Liang Y; Zhang S; Lan Q; Xu Z; Wu X; Kang L; Ren J; Cao Y; Wu T; Lin KL; Yung KKL; Cao X; Pang J; Zhou P ACS Chem Neurosci; 2019 Jun; 10(6):2786-2793. PubMed ID: 30935201 [TBL] [Abstract][Full Text] [Related]
15. TRESK: the lone ranger of two-pore domain potassium channels. Enyedi P; Braun G; Czirják G Mol Cell Endocrinol; 2012 Apr; 353(1-2):75-81. PubMed ID: 22115960 [TBL] [Abstract][Full Text] [Related]
16. A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Lafrenière RG; Cader MZ; Poulin JF; Andres-Enguix I; Simoneau M; Gupta N; Boisvert K; Lafrenière F; McLaughlan S; Dubé MP; Marcinkiewicz MM; Ramagopalan S; Ansorge O; Brais B; Sequeiros J; Pereira-Monteiro JM; Griffiths LR; Tucker SJ; Ebers G; Rouleau GA Nat Med; 2010 Oct; 16(10):1157-60. PubMed ID: 20871611 [TBL] [Abstract][Full Text] [Related]
17. Pranlukast is a novel small molecule activator of the two-pore domain potassium channel TREK2. Wright PD; McCoull D; Walsh Y; Large JM; Hadrys BW; Gaurilcikaite E; Byrom L; Veale EL; Jerman J; Mathie A Biochem Biophys Res Commun; 2019 Nov; 520(1):35-40. PubMed ID: 31564414 [TBL] [Abstract][Full Text] [Related]
18. Chemically Modified Derivatives of the Activator Compound Cloxyquin Exert Inhibitory Effect on TRESK (K Lengyel M; Erdélyi F; Pergel E; Bálint-Polonka Á; Dobolyi A; Bozsaki P; Dux M; Király K; Hegedűs T; Czirják G; Mátyus P; Enyedi P Mol Pharmacol; 2019 Jun; 95(6):652-660. PubMed ID: 30979812 [TBL] [Abstract][Full Text] [Related]
19. Molecular Pharmacology of K Decher N; Rinné S; Bedoya M; Gonzalez W; Kiper AK Cell Physiol Biochem; 2021 Mar; 55(S3):87-107. PubMed ID: 33667333 [TBL] [Abstract][Full Text] [Related]
20. Terbinafine is a novel and selective activator of the two-pore domain potassium channel TASK3. Wright PD; Veale EL; McCoull D; Tickle DC; Large JM; Ococks E; Gothard G; Kettleborough C; Mathie A; Jerman J Biochem Biophys Res Commun; 2017 Nov; 493(1):444-450. PubMed ID: 28882594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]